<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="retraction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006094</article-id><article-id pub-id-type="pmc">PMC11860066</article-id><article-id pub-id-type="doi">10.3390/ph18020226</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-18-00226</article-id><article-categories><subj-group subj-group-type="heading"><subject>Retraction</subject></subj-group></article-categories><title-group><article-title>RETRACTED: Ezz Eldin et al. Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure&#x02013;Activity Relationship Studies. <italic toggle="yes">Pharmaceuticals</italic> 2023, <italic toggle="yes">16</italic>, 1247</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9795-1272</contrib-id><name><surname>Ezz Eldin</surname><given-names>Rogy R.</given-names></name><xref rid="af1-pharmaceuticals-18-00226" ref-type="aff">1</xref><xref rid="c1-pharmaceuticals-18-00226" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Saleh</surname><given-names>Marwa A.</given-names></name><xref rid="af2-pharmaceuticals-18-00226" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5869-8358</contrib-id><name><surname>Alwarsh</surname><given-names>Sefat A.</given-names></name><xref rid="af3-pharmaceuticals-18-00226" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8356-3551</contrib-id><name><surname>Rushdi</surname><given-names>Areej</given-names></name><xref rid="af4-pharmaceuticals-18-00226" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6313-6296</contrib-id><name><surname>Althoqapy</surname><given-names>Azza Ali</given-names></name><xref rid="af4-pharmaceuticals-18-00226" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>El Saeed</surname><given-names>Hoda S.</given-names></name><xref rid="af2-pharmaceuticals-18-00226" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4634-3039</contrib-id><name><surname>Abo Elmaaty</surname><given-names>Ayman</given-names></name><xref rid="af5-pharmaceuticals-18-00226" ref-type="aff">5</xref><xref rid="c1-pharmaceuticals-18-00226" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-pharmaceuticals-18-00226"><label>1</label>Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt</aff><aff id="af2-pharmaceuticals-18-00226"><label>2</label>Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11651, Egypt; <email>marwasaleh577@yahoo.com</email> (M.A.S.); <email>hodasamir3185@gmail.com</email> (H.S.E.S.)</aff><aff id="af3-pharmaceuticals-18-00226"><label>3</label>Department of Science, Prince Sultan Military College of Health Sciences, Dhahran 31932, Saudi Arabia; <email>salwarsh@psmchs.edu.sa</email></aff><aff id="af4-pharmaceuticals-18-00226"><label>4</label>Department of Medical Microbiology and Immunology, Faculty of Medicine for Girls, Al-Azhar University, Cairo 11651, Egypt; <email>areejrushdi@azhar.edu.eg</email> (A.R.); <email>azzaaly.micro@azhar.edu.eg</email> (A.A.A.)</aff><aff id="af5-pharmaceuticals-18-00226"><label>5</label>Medicinal Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt</aff><author-notes><corresp id="c1-pharmaceuticals-18-00226"><label>*</label>Correspondence: <email>rogyezz29@gmail.com</email> (R.R.E.E.); <email>ayman.mohamed@pharm.psu.edu.eg</email> (A.A.E.)</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>07</day><month>2</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>18</volume><issue>2</issue><elocation-id>226</elocation-id><history><date date-type="received"><day>29</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>26</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><related-article related-article-type="retracted-article" ext-link-type="doi" id="ra1-pharmaceuticals-18-00226" xlink:href="10.3390/ph16091247" vol="16" page="1247"/></article-meta></front><body><p>The <italic toggle="yes">Pharmaceuticals</italic> Editorial Office retracts the article &#x0201c;Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure&#x02013;Activity Relationship Studies&#x0201d; [<xref rid="B1-pharmaceuticals-18-00226" ref-type="bibr">1</xref>] cited above.</p><p>Following publication, concerns were raised by the publisher regarding the validity of the data published in this article [<xref rid="B1-pharmaceuticals-18-00226" ref-type="bibr">1</xref>].</p><p>Adhering to our complaints procedure, an investigation was conducted by the Editorial Office and Editorial Board, which included a review of the raw data presented within this publication. While the authors fully cooperated with the investigation, they were unable to satisfactorily address a number of significant errors and anomalies found in the NMR and IR data. As a result, the Editorial Office and Editorial Board were unable to confirm the reliability of the findings and subsequently decided to retract the paper as per MDPI&#x02019;s retraction policy (<uri xlink:href="https://www.mdpi.com/ethics#_bookmark30">https://www.mdpi.com/ethics#_bookmark30</uri>, accessed on 25 October 2024) and in line with the Committee on Publication Ethics retraction guidelines (<uri xlink:href="https://publicationethics.org/retraction-guidelines">https://publicationethics.org/retraction-guidelines</uri>, accessed on 25 October 2024).</p><p>This retraction was approved by the Editor-in-Chief of the journal <italic toggle="yes">Pharmaceuticals</italic>.</p><p>The authors did not agree to this retraction.</p></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><ref-list><title>Reference</title><ref id="B1-pharmaceuticals-18-00226"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ezz Eldin</surname><given-names>R.R.</given-names></name>
<name><surname>Saleh</surname><given-names>M.A.</given-names></name>
<name><surname>Alwarsh</surname><given-names>S.A.</given-names></name>
<name><surname>Rushdi</surname><given-names>A.</given-names></name>
<name><surname>Althoqapy</surname><given-names>A.A.</given-names></name>
<name><surname>El Saeed</surname><given-names>H.S.</given-names></name>
<name><surname>Abo Elmaaty</surname><given-names>A.</given-names></name>
</person-group><article-title>RETRACTED: Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure&#x02013;Activity Relationship Studies</article-title><source>Pharmaceuticals</source><year>2023</year><volume>16</volume><elocation-id>1247</elocation-id><pub-id pub-id-type="doi">10.3390/ph16091247</pub-id><pub-id pub-id-type="pmid">37765055</pub-id>
</element-citation></ref></ref-list></back></article>